Cargando…

Effect of salbutamol on neuromuscular junction function and structure in a mouse model of DOK7 congenital myasthenia

Congenital myasthenic syndromes (CMS) are characterized by fatigable muscle weakness resulting from impaired neuromuscular transmission. β2-adrenergic agonists are an effective treatment for DOK7-CMS. DOK7 is a component within the AGRN-LRP4-MUSK-DOK7 signalling pathway that is key for the formation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Webster, Richard G, Vanhaesebrouck, An E, Maxwell, Susan E, Cossins, Judith A, Liu, Weiwei, Ueta, Ryo, Yamanashi, Yuji, Beeson, David M W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	General Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424765/ https://www.ncbi.nlm.nih.gov/pubmed/32543656 http://dx.doi.org/10.1093/hmg/ddaa116

Ejemplares similares

DOK7 Gene Therapy Enhances Neuromuscular Junction Innervation and Motor Function in Aged Mice
por: Ueta, Ryo, et al.
Publicado: (2020)

β2-Adrenergic receptor agonists ameliorate the adverse effect of long-term pyridostigmine on neuromuscular junction structure
por: Vanhaesebrouck, An E, et al.
Publicado: (2019)

Salbutamol modifies the neuromuscular junction in a mouse model of ColQ myasthenic syndrome
por: McMacken, Grace M, et al.
Publicado: (2019)

Mechanism of disease and therapeutic rescue of Dok7 congenital myasthenia
por: Oury, Julien, et al.
Publicado: (2021)

The Neuromuscular Junction in Health and Disease: Molecular Mechanisms Governing Synaptic Formation and Homeostasis
por: Rodríguez Cruz, Pedro M., et al.
Publicado: (2020)

Dok-1 and Dok-2 are negative regulators of lipopolysaccharide-induced signaling
por: Shinohara, Hisaaki, et al.
Publicado: (2005)

Role of Dok-1 and Dok-2 in Myeloid Homeostasis and Suppression of Leukemia
por: Yasuda, Tomoharu, et al.
Publicado: (2004)

IgG1-3 MuSK Antibodies Inhibit AChR Cluster Formation, Restored by SHP2 Inhibitor, Despite Normal MuSK, DOK7, or AChR Subunit Phosphorylation
por: Cao, Michelangelo, et al.
Publicado: (2023)

Rapsyn facilitates recovery from desensitization in fetal and adult acetylcholine receptors expressed in a muscle cell line
por: Cetin, Hakan, et al.
Publicado: (2019)

The Neuromuscular Junction and Wide Heterogeneity of Congenital Myasthenic Syndromes
por: Rodríguez Cruz, Pedro M., et al.
Publicado: (2018)

Myasthenia gravis AChR antibodies inhibit function of rapsyn-clustered AChRs
por: Cetin, Hakan, et al.
Publicado: (2020)

The congenital myasthenic syndromes: expanding genetic and phenotypic spectrums and refining treatment strategies
por: Vanhaesebrouck, An E., et al.
Publicado: (2019)

Neuromuscular junction involvement in inherited motor neuropathies: genetic heterogeneity and effect of oral salbutamol treatment
por: McMacken, Grace, et al.
Publicado: (2023)

Complement deposition at the neuromuscular junction in seronegative myasthenia gravis
por: Hoffmann, Sarah, et al.
Publicado: (2020)

The beta-adrenergic agonist salbutamol modulates neuromuscular junction formation in zebrafish models of human myasthenic syndromes
por: McMacken, Grace, et al.
Publicado: (2018)

Autoimmunity strikes neuromuscular junction: Myasthenia gravis & achalasia cardia
por: Sulena,, et al.
Publicado: (2020)

DOK7 gene therapy enhances motor activity and life span in ALS model mice
por: Miyoshi, Sadanori, et al.
Publicado: (2017)

When Breathing Becomes a Challenge: A Case of Congenital Myasthenia Gravis in an Indian Neonate With a DOK-7 Gene Mutation
por: Mendpara, Vaidehi, et al.
Publicado: (2023)

Role of Dok-1 and Dok-2 in Leukemia Suppression
por: Niki, Masaru, et al.
Publicado: (2004)

Loss of Dok-3 in Non-tumor Cells Induces Malignant Transformation of Benign Epithelial Tumor Cells of the Intestine
por: Arimura, Sumimasa, et al.
Publicado: (2022)

Myasthenia gravis-like syndrome induced by expression of interferon gamma in the neuromuscular junction
Publicado: (1995)

A rare c.183_187dupCTCAC mutation of the acetylcholine receptor CHRNE gene in a South Asian female with congenital myasthenic syndrome: a case report
por: Chang, Thashi, et al.
Publicado: (2016)

MuSK Myasthenia Gravis IgG4 Disrupts the Interaction of LRP4 with MuSK but Both IgG4 and IgG1-3 Can Disperse Preformed Agrin-Independent AChR Clusters
por: Koneczny, Inga, et al.
Publicado: (2013)

Congenital myasthenic syndrome due to a TOR1AIP1 mutation: a new disease pathway for impaired synaptic transmission
por: Cossins, Judith, et al.
Publicado: (2020)

Novel p62dok family members, dok-4 and dok-5, are substrates of the c-Ret receptor tyrosine kinase and mediate neuronal differentiation
por: Grimm, Jan, et al.
Publicado: (2001)

The role of Rapsyn in neuromuscular junction and congenital myasthenic syndrome
por: Liao, Xufeng, et al.
Publicado: (2023)

Animal Models of the Neuromuscular Junction, Vitally Informative for Understanding Function and the Molecular Mechanisms of Congenital Myasthenic Syndromes
por: Webster, Richard G.
Publicado: (2018)

Effects of expressing human T-cell leukemia virus type 1 (HTLV-I) oncoprotein Tax on DOK1, DOK2 and DOK3 gene expression in mice
por: OHSUGI, Takeo
Publicado: (2017)

Congenital Myasthenic Syndrome due to DOK7 mutations in a family from Chile
por: Bevilacqua, Jorge A., et al.
Publicado: (2017)

Intragenic DOK7 deletion detected by whole-genome sequencing in congenital myasthenic syndromes
por: Azuma, Yoshiteru, et al.
Publicado: (2017)

IgG1 antibodies to acetylcholine receptors in ‘seronegative’ myasthenia gravis(†)
por: Leite, Maria Isabel, et al.
Publicado: (2008)

Predictors of transient congenital primary hypothyroidism: data from the German registry for congenital hypothyroidism (AQUAPE “HypoDok”)
por: Matejek, Nicola, et al.
Publicado: (2021)

Salbutamol and around
por: Ullmann, N, et al.
Publicado: (2015)

A mutation in DOK7 in congenital myasthenic syndrome forms aggresome in cultured cells, and reduces DOK7 expression and MuSK phosphorylation in patient-derived iPS cells
por: Zhang, Shaochuan, et al.
Publicado: (2022)

Mutations in MUSK causing congenital myasthenic syndrome impair MuSK–Dok-7 interaction
por: Maselli, Ricardo A., et al.
Publicado: (2010)

Guideline Adherence and Registry Recruitment of Congenital Primary Hypothyroidism: Data from the German Registry for Congenital Hypothyroidism (HypoDok)
por: Thomann, Julia, et al.
Publicado: (2021)

SHP2 inhibitor protects AChRs from effects of myasthenia gravis MuSK antibody
por: Huda, Saif, et al.
Publicado: (2019)

Long-term muscle-specific overexpression of DOK7 in mice using AAV9-tMCK-DOK7
por: Huang, Yu-Ting, et al.
Publicado: (2023)

Expression and significance of DOK2 in colorectal cancer
por: WEN, XIANMEI, et al.
Publicado: (2015)

DOK2 Inhibits EGFR-Mutated Lung Adenocarcinoma
por: Berger, Alice H., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_07vujdngc6tmfh7ct0e2ecj2l8